Ruxolitinib
1 NDC across 1 manufacturer|0 Generic,1 Brand
Ruxolitinib is used to treat polycythemia vera and primary myelofibrosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Ruxolitinib is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $34.01 to $34.01 per GM. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$34.01 – $34.01
per GM
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Incyte Corporation manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Janus Kinase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing RUXOLITINIB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
OPZELURA 1.5% CREAM | $34.0119 per GM | +0.04% |
Frequently Asked Questions
What is Ruxolitinib used to treat?
Ruxolitinib is used to treat polycythemia vera and primary myelofibrosis, per the National Library of Medicine's MED-RT classification.
How many Ruxolitinib products are on the market?
The Ruxolitinib drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Ruxolitinib?
NADAC reference prices for Ruxolitinib range from $34.0119 to $34.0119 per GM.
Which manufacturers make Ruxolitinib?
1 manufacturer lists Ruxolitinib in NADAC. Ranked by number of NDCs, the largest are Incyte Corporation (1).
How has the price of Ruxolitinib changed recently?
Over the past 7 days, 2 Ruxolitinib NDCs rose and 0 fell, with a market-wide average change of +0.0%.